电邮这篇文章 New coronavirus infection COVID-19 as a trigger for the development of symptoms of ankylosing spondylitis. Case report
- 作者: Rumiantceva D.1, Urumova M.1, Erdes S.1
-
隶属关系:
- Nasonova Research Institute of Rheumatology
- 期: 卷 93, 编号 5 (2021)
- 页面: 609–612
- 栏目: Clinical notes
- URL: https://journals.rcsi.science/0040-3660/article/view/71517
- DOI: https://doi.org/10.26442/00403660.2021.05.200793
- ID: 71517
如何引用文章
全文:
详细
The novel coronavirus infection COVID-19 (SARS-CoV-2) is now known to cause a variety of extrapulmonary complications, including cardiovascular, neurological and dermatological complications, many of which occur or last several weeks after infection. We present a clinical case of a patient who first developed symptoms of ankylosing spondylitis 2 weeks after recovering from COVID-19. The patient was prescribed therapy in accordance with international and Russian recommendations for the management of patients with ankylosing spondylitis with a positive effect in the form of absence arthritis, enthesitis and reducing the inflammatory back pain.
作者简介
Daria Rumiantceva
Nasonova Research Institute of Rheumatology
编辑信件的主要联系方式.
Email: rumiantceva01@gmail.com
ORCID iD: 0000-0002-1684-1213
канд. мед. наук, мл. науч. сотр. лаб. спондилоартритов и псориатического артрита
俄罗斯联邦, MoscowMargarita Urumova
Nasonova Research Institute of Rheumatology
Email: rumiantceva01@gmail.com
ORCID iD: 0000-0002-9755-5760
канд. мед. наук, зав. 2-м ревматологическим отд-нием
俄罗斯联邦, MoscowShandor Erdes
Nasonova Research Institute of Rheumatology
Email: rumiantceva01@gmail.com
ORCID iD: 0000-0003-3195-5187
д-р мед. наук, проф., вед. науч. сотр. лаб. спондилоартритов и псориатического артрита
俄罗斯联邦, Moscow参考
- Wang H, Li X, Li T, et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020;39(9):1629-35. doi: 10.1007/s10096-020-03899-4
- WHO Coronavirus (COVID-19) Dashboard. Available: https://covid19.who.int. Accessed: 05.05.2021.
- Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568-76. doi: 10.1002/jmv.25748
- Guan WJ, Zhong NS. Clinical characteristics of Covid-19 in China. N Engl J Med. 2020;382(19):1861–2. doi: 10.1056/nejmc2005203
- Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):a multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80:388-93. doi: 10.1016/j.jinf.2020.02.016
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-13. doi: 10.1016/s0140-6736(20)30211-7
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-Infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-9. doi: 10.1001/jama.2020.1585
- Xie HT, Jiang SY, Xu KK, et al. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vis (Lond). 2020;7:23. doi: 10.1186/s40662-020-00189-0
- Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1-9. doi: 10.1001/jamaneurol.2020.1127
- Wang L, Wang Y, Ye D, et al. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020;55:105948. doi: 10.1016/j.ijantimicag.2020.105948 11. Ono K, Kishimoto M, Shimasaki T, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020;6:e001350. doi: 10.1136/rmdopen-2020-001350
- Эрдес Ш.Ф., Бадокин В.В., Бочкова А.Г., и др. О терминологии спондилоартритов. Научно-практическая ревматология. 2015;53(6):657-60 [Erdes SF, Badokin VV, Bochkova AG, et al. On the terminology of spondyloarthritis. Rheumatology Science and Practice. 2015;53(6):657-60 (in Russian)]. doi: 10.14412/1995-4484-2015-657-660
- Wan S, Yi Q, Fan S, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv. 2020. doi: 10.1101/2020.02.10.20021832
- Насонов Е.Л. Иммунопатология и иммунофармакотерапия коронавирусной болезни 2019 (COVID-19): фокус на интерлейкин 6. Научно- практическая ревматология. 2020;58(3):245-61 [Nasonov EL. Immunopathology and immunopharmacotherapy of coronavirus disease 2019 (COVID-19): focus on interleukin 6. Rheumatology Science and Practice. 2020;58(3):245-61 (in Russian)]. doi: 10.14412/1995-4484-2020-245-261
- Liu Y, Zhang C, Huang F, et al. Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury. Nat Sci Rev. 2020:nwaa037. doi: 10.1093/nsr/nwaa037
- Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763.
补充文件
